Bbm:978-1-4614-3564-8/1.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Bbm:978-1-4614-3564-8/1.Pdf Index A trichrome , 37 Acanthosis nigricans , 127 vulgaris , 36–37 Acneiform illnesses Wood’s lamp , 37 acne keloidalis nuchae , 20 Acral lentiginosis , 30 acne scarred , 17 Acral melanocytic nevi , 24–25 acne vulgaris , 15–16 Adams–Oliver syndrome , 49 Crohn’s disease , 17 Addison’s disease , 8 cystic acne , 17 Allergic contact dermatitis , 83–85 hidradenitis suppurativa , 17–19 Alopecia infantile acropustulosis , 19–20 football-shaped , 102 isotretinoin Hispanic effects , 16–17 traction , 102, 103 minocycline-induced hyperpigmentation , 19 Ashy dermatosis , 39–40 neonatal acne , 11–12 Atopic dermatitis perioral dermatitis , 12–13 Branny scale , 78 pityrosporum folliculitis , 14 children , 69–71 pomade acne , 14–15 dermoscopy , 76 preteen acne , 13–14 facial , 72–74 steroid acne , 19 fl exural , 75–76 treatment , 17, 18 follicular , 75 Acquired ochronosis , 43 infantile , 72, 74 Acquired pigmentary alterations lichenoid , 78 acquired ochronosis , 43 lichen planus-like , 78 ashy dermatosis , 39–40 superinfected , 77 border hyperpigmentation , 39 Atrophic scars , 99 callosity , 42 Autoimmune/collagen vascular disease , 95 cupping , 42 erythema dyschromicum perstans , 39–40 follicular repigmentation , 39 B frictional hyperpigmentation , 41 Becker’s nevus , 31 Laugier-Hunziker , 35–36 Bedbugs , 119–120 lichen simplex chronicus , 42 Black dot tinea , 116 los senescientos , 39–40 Border hyperpigmentation , 39 melanonychia striata hispanic , 35 Branny scale , 78 oral mucosal hyperpigmentation , 42 Buschke-Fischer-Brauer disease , 66 oral papillary hyperpigmentation , 40 progressive macular hypomelanosis , 40 Pseudo-Hutchinson’s sign , 36 C retention hyperkeratosis , 41–42 Café au lait macules , 27 SCURF-acquired hyperpigmentation , 41–42 Callosity , 42 skin hyperpigmentation , 42 Carney complex , 30 terra fi rma , 41–42 CARP. See Con fl uent and reticulated vitiligo papillomatosis (CARP) prominence , 38, 39 Cell phone allergy , 85 speckled type, vitamin D , 37–38 Cerebral cavernous malformations , 50 N.B. Silverberg, Atlas of Pediatric Cutaneous Biodiversity: Comparative Dermatologic Atlas of Pediatric Skin of All Colors, 133 DOI 10.1007/978-1-4614-3564-8, © Springer Science+Business Media, LLC 2012 134 Index Chicken pox , 122–123 fl at warts , 113–114 Children impetigo , 125 acneiform illnesses kerions , 116–117 acne keloidalis nuchae , 20 molluscum contagiosum , 117–118 acne scarred , 17 myiasis , 122 acne vulgaris , 15–16 pityriasis versicolor , 114–115 Crohn’s disease , 17 scabies , 120–121 cystic acne , 17 scalp dermatophyte infection , 116 hidradenitis suppurativa , 17–19 scarlet fever , 123–124 infantile acropustulosis , 19–20 tinea capitis , 115–117 isotretinoin Hispanic effects , 16–17 tinea pedis , 119 minocycline-induced hyperpigmentation , 19 tinea versicolor , 114–115 neonatal acne , 11–12 varicella zoster infection , 121–122 perioral dermatitis , 12–13 viral exanthems , 124 pityrosporum folliculitis , 14 white piedra , 117 pomade acne , 14–15 dermal disease preteen acne , 13–14 atrophic scar , 99 steroid acne , 19 granuloma annulare , 99 treatment , 17, 18 lipoid proteinosis , 97 acquired pigmentary alterations striae , 97–99 acquired ochronosis , 43 urticaria , 99–100 ashy dermatosis , 39–40 dermato fi bromas , 108 border hyperpigmentation , 39 diffuse mastocytosis , 111 callosity , 42 eczematous diseases cupping , 42 allergic contact dermatitis , 83–85 erythema dyschromicum perstans , 39–40 Branny scale , 78 follicular repigmentation , 39 cell phone allergy , 85 frictional hyperpigmentation , 41 Dennie Morgan fold , 81 Laugier-Hunziker , 35–36 dermatitis erythema nuchae , 79 lichen simplex chronicus , 42 diaper dermatitis , 86–87 los senescientos , 39–40 eczema herpeticum , 79 melanonychia striata hispanic , 35 erythroderma and generalized licheni fi cation , 78 oral mucosal hyperpigmentation , 42 facial atopic dermatitis , 72–74 oral papillary hyperpigmentation , 40 fl aggrin mutations , 69 progressive macular hypomelanosis , 40 fl exural atopic dermatitis , 75–76 Pseudo-Hutchinson’s sign , 36 follicular atopic dermatitis , 75 retention hyperkeratosis , 41–42 hand eczema , 82 SCURF-acquired hyperpigmentation , 41–42 hypopigmentation , 74 skin hyperpigmentation , 42 infantile atopic dermatitis , 72, 74 terra fi rma , 41–42 infantile seborrheic dermatitis , 82–83 trichrome vitiligo , 37 irritant contact dermatitis , 87 vitiligo vulgaris , 36–37 juvenile plantar dermatosis , 77 Wood’s lamp , 37 keratosis pilaris , 79–81 Buschke-Fischer-Brauer disease , 66 licheni fi cation , 76–77 collagen vascular diseases lichenoid atopic dermatitis , 78 ephelides , 92 lichen striatus , 85–86 extensive sun damage , 92 nipple eczema , 81–82 infantile sunburn , 93 superinfected atopic dermatitis , 77 juvenile dermatomyositis , 94–95 epidermolytic hyperkeratosis , 62 morphea , 93–94 harlequin ichthyosis , 64 neonatal lupus , 89–91 ichthyosis vulgaris , 61–62 photosensitivity , 89 juvenile xanthogranuloma , 109 phytophotodermatitis , 93 keloids , 107 poikiloderma , 92 lamellar ichthyosis , 62–63 Rothmund Thomson syndrome , 92 linear porokeratosis , 65 systemic lupus erythematosus , 91–92 lymphocytic illnesses congenital ichthyosiform erythroderma , 63 mycosis fungoides , 130 cutaneous infections pityriasis lichenoides , 129–130 bedbugs , 119–120 mastocytoma , 109–110 black dot tinea , 116 metabolic syndrome CARP , 118–119 acanthosis nigricans , 127 chicken pox , 122–123 dermatologic fi ndings , 128 cimex lectularis , 120 obesity , 129 common warts , 113 skin tags , 128, 129 cutaneous larva migrans , 121 normal skin Dermatobia hominis , 121 Asian hair infant and toddler , 6–7 fi fth’s disease , 124 black child , 7 Index 135 Caucasian hair whorl , 6 CARP , 118–119 dorsal/ventral demarcation , 5 chicken pox , 122–123 Fitzpatrick phototyping scale , 1, 2 cimex lectularis , 120 gum hyperpigmentation , 8 common warts , 113 Hispanic hair whorl , 7 cutaneous larva migrans , 121 linea nigra , 6 Dermatobia hominis , 121 periocular hyperpigmentation , 6 fi fth’s disease , 124 scrotum hyperpigmentation , 8 fl at warts , 113–114 skin demarcation , 5 impetigo , 125 palmoplantar keratoderma , 65–66 kerions , 116–117 papulosquamous disorders molluscum contagiosum , 117–118 facial psoriasis , 54 myiasis , 122 forehead psoriasis , 54 pityriasis versicolor , 114–115 guttate psoriasis , 56 scabies , 120–121 inverse psoriasis , 57–58 scalp dermatophyte infection , 116 lichen planus , 59–60 scarlet fever , 123–124 micaceous scale , 55 tinea capitis , 115–117 nappy psoriasis , 57–58 tinea pedis , 119 pityriasis amiantacea , 53 tinea versicolor , 114–115 pityriasis rosea , 58–59 varicella zoster infection , 121–122 postin fl ammatory hyperpigmentation , 54–55 viral exanthems , 124 psoriasis vulgaris , 53 white piedra , 117 scalp disease , 54–55 Cutaneous larva migrans , 121 trachyonychia , 57 Cutis marmorata telangiectatica congenital (CMTC) , 45–46 unilateral laterothoracic exanthem , 59 Cystic acne , 17 Woronoff rings , 56 piercings , 107 porokeratosis , 64–65 D punctate palmoplantar keratoderma , 66 Dark congenital melanocytic nevi , 26 syringomas , 108 Dennie Morgan fold , 81 urticaria pigmentosa , 110 Dermal disease vascular birthmarks atrophic scar , 99 CMTC , 45–46 granuloma annulare , 99 congenital hemangioma , 50 lipoid proteinosis , 97 hemangiomas of infancy , 49 striae , 97–99 infantile hemangiomas , 47–50 urticaria , 99–100 nevus simplex , 46 Dermatitis port wine stain , 46–47 erythema nuchae , 79 spider angioma , 50 perioral , 12–13 Cimex lectularis , 120 periori fi cial , 12–13 CMTC. See Cutis marmorata telangiectatica congenital (CMTC) phytophotodermatitis , 93 Collagen vascular diseases Dermatobia hominis , 121 ephelides , 92 Dermato fi bromas , 108 extensive sun damage , 92 Diaper dermatitis , 86–87 infantile sunburn , 93 Diffuse mastocytosis , 111 juvenile dermatomyositis , 94–95 Divided nevi , 26 morphea , 93–94 Dorsal/ventral demarcation , 5 neonatal lupus Down’s syndrome , 104 CMTC-like , 90 Dysplastic nevus , 25–26 description , 89–90 sequelae , 91 photosensitivity , 89 E phytophotodermatitis , 93 Eclipse nevus , 23–24 poikiloderma , 92 Eczema herpeticum , 79 Rothmund Thomson syndrome , 92 Eczematous diseases systemic lupus erythematosus , 91–92 allergic contact dermatitis , 83–85 Common warts , 113 atopic dermatitis Con fl uent and reticulated papillomatosis (CARP) , 118–119 Branny scale , 78 Congenital hemangioma , 50 children , 69–71 Congenital ichthyosiform erythroderma , 63 dermoscopy , 76 Congenital melanocytic nevus , 25 facial , 72–74 Contact dermatitis , 84 fl exural , 75–76 Crohn’s disease , 17 follicular , 75 Cupping , 42 infantile , 72, 74 Cutaneous infections lichenoid , 78 bedbugs , 119–120 lichen planus-like , 78 black dot tinea , 116 superinfected , 77 136 Index Eczematous diseases (cont.) Hidradenitis suppurativa , 17–19 cell phone allergy , 85 HPV/Warts , 113, 114 Dennie Morgan fold , 81 Hyperpigmentation dermatitis erythema nuchae , 79 diffuse mastocytosis , 111 diaper dermatitis , 86–87 fl exural atopic dermatitis , 75–76 eczema herpeticum , 79 gum , 8 erythroderma and generalized licheni fi cation , 78 juvenile dermatomyositis , 94–95 fl aggrin mutations , 69 minocycline-induced , 19 hand eczema , 82 oral mucosal , 42 hypopigmentation , 74 oral papillary , 40 infantile seborrheic dermatitis , 82–83 periocular , 6 irritant contact dermatitis , 87 postin fl ammatory , 54–55 juvenile plantar dermatosis , 77 scrotum , 8 keratosis pilaris segmental , 31 description , 79–80 urticaria pigmentosa , 110 rubra faciei , 80–81 Hypertrichosis ,
Recommended publications
  • Where Does Psoriasis Fit
    Dr Shan Edwards Dermatologist Dermatology Clinic, Christchurch 11:00 - 11:55 WS #86: Differential Diagnosis Based on Classic Location - Where Does Psoriasis Fit In? 12:05 - 13:00 WS #97: Differential Diagnosis Based on Classic Location - Where Does Psoriasis Fit In? (Repeated) Differential diagnosis based on classic location Where does psoriasis fit in? Dr Shan Edwards , dermatologist Christchurch 2016 2 Conflict statement . This talk sponsored by LEO Pharma Pty Ltd . I have no other association financial or otherwise with LEO Pharma Pty Ltd 3 Acknowedgement I wish to thank and acknowledge and thank A/Prof Amanda Oakley for providing a lot of the material and allowing me to use it in this talk I would also like to acknowledge Dermnet NZ as a source for most of my clinical slides 4 How do you diagnose red scaly skin ? Take a history (90% diagnosis made on history) . When did scaly rash first appear? . What do you think caused it? . What treatments used and their effects? . Personal history of skin problems ? . Family history of similar disorders? . Occupation, hobbies, other life events? . Symptoms: itch? Other eg fever, weightloss unwell Other medical problems?(co-morbidities) . Current medicines : how long, any new ? 7 When did scaly rash first appear? . Infancy: seborrhoeic dermatitis/eczema . Toddler: atopic dermatitis/eczema . Pre-schooler/primary school: tinea capitis/corporis . Primary school: head lice . Teenage/adult: seborrhoeic dermatitis/eczema, psoriasis . Adult/elderly: drug rash, lymphoma, other less common skin conditions(PRP,Lupus) . All age groups:scabies 8 Dear Shan Re: Miss EM age 7yrs I am completely puzzled by EM’s rash and particularly so since there now appear to be other areas of her body being affected by it.
    [Show full text]
  • Il-23, a Novel Marker in the Diagnosis of Psoriasis
    IL-23, A NOVEL MARKER IN THE DIAGNOSIS OF PSORIASIS Dissertation submitted to The Tamilnadu Dr.MGR Medical University In partial fulfillment of the regulations for the award of the degree of M.D.BIOCHEMISTRY Branch XIII DEPARTMENT OF BIOCHEMISTRY KILPAUK MEDICAL COLLEGE CHENNAI - 600010. THE TAMILNADU DR.MGR MEDICAL UNIVERSITY CHENNAI-600032 APRIL-2017 CERTIFICATE This to certify that the dissertation entitled “IL-23, A NOVEL MARKER IN THE DIAGNOSIS OF PSORIASIS”- A CASE CONTROL STUDY is the bonafide original work done by DR.G.EZHIL, Post graduate in Biochemistry under overall supervision and guidance in the Department of Biochemistry, Kilpauk Medical College, Chennai, in partial fulfillment of the regulations of The Tamilnadu Dr. M.G.R . Medical University for the award of M.D. Degree in Biochemistry (Branch XIII) Dr. NARAYANA BABU., M.D.DCH Dr . V. MEERA,M.D DEAN, PROFESSOR & HEAD, Kilpauk Medical College, Department of Biochemistry, Chennai – 600010. Kilpauk Medical College, Chennai – 600010 Date : Date: Station: Station: DECLARATION I solemnly declare that this dissertation entitled “IL-23, A NOVEL MARKER IN THE DIAGNOSIS OF PSORIASIS”- A CASE CONTROL STUDY was written by me in the Department of Biochemistry, Kilpauk Medical College, Chennai, under the guidance and supervision of Prof. DR.V.MEERA,M.D., Professor & HOD, Department of Biochemistry & Kilpauk Medical College, Chennai – 600010. This dissertation is submitted to THE TAMILNADU Dr.M.G.R MEDICAL UNIVERSITY Chennai, in partial fulfillment of the university regulations for the award of DEGREE OF M.DBIOCHEMISTRY(BRANCH - XIII) examinations to be held in APRIL – 2017. Date : Place : Chennai Dr.G.EZHIL ACKNOWLEDGEMENT “Gratitude is the humble gift, I can give to my beloved Teachers”.
    [Show full text]
  • (CD-P-PH/PHO) Report Classification/Justifica
    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
    [Show full text]
  • Autoinvolutive Photoexacerbated Tinea Corporis Mimicking a Subacute Cutaneous Lupus Erythematosus
    Letters to the Editor 141 low-potency steroids had no eŒect. Our patient was treated 4. Jarrat M, Ramsdell W. Infantile acropustulosis. Arch Dermatol with a modern glucocorticoid which has an improved risk– 1979; 115: 834–836. bene t ratio. The antipruritic and anti-in ammatory properties 5. Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol of the steroid were increased by applying it in combination 1979; 115: 831–833. 6. Newton JA, Salisbury J, Marsden A, McGibbon DH. with a wet-wrap technique, which has already been shown to Acropustulosis of infancy. Br J Dermatol 1986; 115: 735–739. be extremely helpful in cases of acute exacerbations of atopic 7. Mancini AJ, Frieden IJ, Praller AS. Infantile acropustulosis eczema in combination with (3) or even without topical revisited: history of scabies and response to topical corticosteroids. steroids (8). Pediatr Dermatol 1998; 15: 337–341. 8. Abeck D, Brockow K, Mempel M, Fesq H, Ring J. Treatment of acute exacerbated atopic eczema with emollient-antiseptic prepara- tions using ‘‘wet-wrap’’ (‘‘wet-pyjama’’) technique. Hautarzt 1999; REFERENCES 50: 418–421. 1. Vignon-Pennam en M-D, Wallach D. Infantile acropustulosis. Arch Dermatol 1986; 122: 1155–1160. Accepted November 24, 2000. 2. Duvanel T, Harms M. Infantile Akropustulose. Hautarzt 1988; 39: 1–4. Markus Braun-Falco, Silke Stachowitz, Christina Schnopp, Johannes 3. Oranje AP, Wolkerstorfer A, de Waard-van der Spek FB. Treatment Ring and Dietrich Abeck of erythrodermic atopic dermatitis with ‘‘wet-wrap’’ uticasone Klinik und Poliklinik fu¨r Dermatologie und Allergologie am propionate 0,05% cream/emollient 1:1 dressing.
    [Show full text]
  • Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy 449
    Actas Dermosifiliogr. 2019;110(6):448---459 CONSENSUS DOCUMENT Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncologyଝ a b c d e f O. Sanmartín, C. Beato, H. Jin Suh-Oh, I. Aragón, A. Espana,˜ M. Majem, g h i,∗ j S. Segura, A. Gúrpide, R. Botella, C. Grávalos a Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Espana˜ b Departamento de Oncología Médica, Hospital Universitario Virgen Macarena, Sevilla, Espana˜ c Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Espana˜ d Departamento de Oncología Médica, Complejo Hospitalario Universitario de Huelva, Huelva, Espana˜ e Servicio de Dermatología, Clínica Universitaria de Navarra, Pamplona, Espana˜ f Departamento de Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana˜ g Servicio de Dermatología, Hospital del Mar, Barcelona, Espana˜ h Departamento de Oncología Médica, Clínica Universitaria de Navarra, Pamplona, Espana˜ i Servicio de Dermatología, Hospital Universitario La Fe, Facultad de Medicina, Universidad de Valencia, Valencia, Espana˜ j Servicio de Oncología Médica, Hospital Universitario Doce de Octubre, Madrid, Espana˜ KEYWORDS Abstract Although the arrival of new chemotherapy drugs and combinations has brought Chemotherapy; progress in terms of cancer patient survival, they entail many adverse effects that can Photosensitivity; compromise treatment, and hence
    [Show full text]
  • ORIGINAL ARTICLE a Clinical and Histopathological Study of Lichenoid Eruption of Skin in Two Tertiary Care Hospitals of Dhaka
    ORIGINAL ARTICLE A Clinical and Histopathological study of Lichenoid Eruption of Skin in Two Tertiary Care Hospitals of Dhaka. Khaled A1, Banu SG 2, Kamal M 3, Manzoor J 4, Nasir TA 5 Introduction studies from other countries. Skin diseases manifested by lichenoid eruption, With this background, this present study was is common in our country. Patients usually undertaken to know the clinical and attend the skin disease clinic in advanced stage histopathological pattern of lichenoid eruption, of disease because of improper treatment due to age and sex distribution of the diseases and to difficulties in differentiation of myriads of well assess the clinical diagnostic accuracy by established diseases which present as lichenoid histopathology. eruption. When we call a clinical eruption lichenoid, we Materials and Method usually mean it resembles lichen planus1, the A total of 134 cases were included in this study prototype of this group of disease. The term and these cases were collected from lichenoid used clinically to describe a flat Bangabandhu Sheikh Mujib Medical University topped, shiny papular eruption resembling 2 (Jan 2003 to Feb 2005) and Apollo Hospitals lichen planus. Histopathologically these Dhaka (Oct 2006 to May 2008), both of these are diseases show lichenoid tissue reaction. The large tertiary care hospitals in Dhaka. Biopsy lichenoid tissue reaction is characterized by specimen from patients of all age group having epidermal basal cell damage that is intimately lichenoid eruption was included in this study. associated with massive infiltration of T cells in 3 Detailed clinical history including age, sex, upper dermis. distribution of lesions, presence of itching, The spectrum of clinical diseases related to exacerbating factors, drug history, family history lichenoid tissue reaction is wider and usually and any systemic manifestation were noted.
    [Show full text]
  • Clinical Study of Nail Changes in Papulosquamous Disorders
    Original Research Article Clinical study of Nail changes in papulosquamous disorders Vishal Wali1, Trivedi Rahul Prasad2* 1Associate Professor, 2Post Graduate, Department of Dermatology, Venereology and Leprology, Mahadevappa Rampure Medical College, Sedam Road, Kalaburagi (Gulbarga) 585105, Karnataka, INDIA. Email: [email protected] Abstract Background: Nail disorders comprise ~10% of all dermatologic conditions. Nail disorders include those abnormalities that effect any portion of the nail unit. The nail unit includes the plate, matrix, bed, proximal and lateral folds, hyponychium, and some definitions include the underlying distal phalanx. These structures may be effected by heredity, skin disorders, infections, systemic disease, and aging process, internal and external medications, physical and environmental agents, trauma, and tumours, both benign and malignant. The main contributors being papulosquamous disorder. Nail changes in papulosquamous disorder have been inadequately discussed and only limited studies are present. This study aims to throw some light about frequency of nail involvement in papulosquamous disorders and its various patterns. Methodology: This is the descriptive study. It was conducted in department of DVL of Mahadevappa Rampura Medical college and Basaveshwar teaching and general hospital, Kalaburagi from July 2019 to Feb 2021. General, systemic and dermatological examinations were done. Nails were examined in detail. Special investigations like skin biopsy and potassium hydroxide (KOH) mount was done in relevant cases. Results: There were 50 cases of papulosquamous disorder. The most common papulosquamous disorder was psoriasis, followed by lichen planus and PRP. Out of these the most common nail change was pitting (81%) and lest common was dorsal pterygium (%) Conclusion: Nail being an important appendage affecting various dermatosis and acts as window in diagnosis.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Cutaneous Manifestations of Newborns in Omdurman Maternity Hospital
    ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ Cutaneous Manifestations of Newborns in Omdurman Maternity Hospital A thesis submitted in the partial fulfillment of the degree of clinical MD in pediatrics and child health University of Khartoum By DR. AMNA ABDEL KHALIG MOHAMED ATTAR MBBS University of Khartoum Supervisor PROF. SALAH AHMED IBRAHIM MD, FRCP, FRCPCH Department of Pediatrics and Child Health University of Khartoum University of Khartoum The Graduate College Medical and Health Studies Board 2008 Dedication I dedicate my study to the Department of Pediatrics University of Khartoum hoping to be a true addition to neonatal care practice in Sudan. i Acknowledgment I would like to express my gratitude to my supervisor Prof. Salah Ahmed Ibrahim, Professor of Peadiatric and Child Health, who encouraged me throughout the study and provided me with advice and support. I am also grateful to Dr. Osman Suleiman Al-Khalifa, the Dermatologist for his support at the start of the study. Special thanks to the staff at Omdurman Maternity Hospital for their support. I am also grateful to all mothers and newborns without their participation and cooperation this study could not be possible. Love and appreciation to my family for their support, drive and kindness. ii Table of contents Dedication i Acknowledgement ii Table of contents iii English Abstract vii Arabic abstract ix List of abbreviations xi List of tables xiii List of figures xiv Chapter One: Introduction & Literature Review 1.1 The skin of NB 1 1.2 Traumatic lesions 5 1.3 Desquamation 8 1.4 Lanugo hair 9 1.5
    [Show full text]
  • Acne in Childhood: an Update Wendy Kim, DO; and Anthony J
    FEATURE Acne in Childhood: An Update Wendy Kim, DO; and Anthony J. Mancini, MD cne is the most common chron- ic skin disease affecting chil- A dren and adolescents, with an 85% prevalence rate among those aged 12 to 24 years.1 However, recent data suggest a younger age of onset is com- mon and that teenagers only comprise 36.5% of patients with acne.2,3 This ar- ticle provides an overview of acne, its pathophysiology, and contemporary classification; reviews treatment op- tions; and reviews recently published algorithms for treating acne of differing levels of severity. Acne can be classified based on le- sion type (morphology) and the age All images courtesy of Anthony J. Mancini, MD. group affected.4 The contemporary Figure 1. Comedonal acne. This patient has numerous closed comedones (ie, “whiteheads”). classification of acne based on sev- eral recent reviews is addressed below. Acne lesions (see Table 1, page 419) can be divided into noninflammatory lesions (open and closed comedones, see Figure 1) and inflammatory lesions (papules, pustules, and nodules, see Figure 2). The comedone begins with Wendy Kim, DO, is Assistant Professor of In- ternal Medicine and Pediatrics, Division of Der- matology, Loyola University Medical Center, Chicago. Anthony J. Mancini, MD, is Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children’s Hospital of Chi- cago. Address correspondence to: Anthony J. Man- Figure 2. Moderate mixed acne. In this patient, a combination of closed comedones, inflammatory pap- ules, and pustules can be seen. cini, MD, Division of Dermatology Box #107, Ann and Robert H.
    [Show full text]
  • Drug Treatments in Psoriasis
    Drug Treatments in Psoriasis Authors: David Gravette, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Morgan Luger, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Jay Moulton, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Wesley T. Lindsey, Pharm.D., Associate Clinical Professor of Pharmacy Practice, Drug Information and Learning Resource Center, Harrison School of Pharmacy, Auburn University Universal Activity #: 0178-0000-13-108-H01-P | 1.5 contact hours (.15 CEUs) Initial Release Date: November 29, 2013 | Expires: April 1, 2016 Alabama Pharmacy Association | 334.271.4222 | www.aparx.org | [email protected] SPRING 2014: CONTINUING EDUCATION |WWW.APARX.Org 1 EducatiONAL OBJECTIVES After the completion of this activity pharmacists will be able to: • Outline how to diagnose psoriasis. • Describe the different types of psoriasis. • Outline nonpharmacologic and pharmacologic treatments for psoriasis. • Describe research on new biologic drugs to be used for the treatment of psoriasis as well as alternative FDA uses for approved drugs. INTRODUCTION depression, and even alcoholism which decreases their quality of Psoriasis is a common immune modulated inflammatory life. It is uncertain why these diseases coincide with one another, disease affecting nearly 17 million people in North America and but it is hypothesized that the chronic inflammatory nature of Europe, which is approximately 2% of the population. The highest psoriasis is the underlying problem. frequencies occur in Caucasians
    [Show full text]